The store will not work correctly when cookies are disabled.
N,N-dimethyl-4-[6-(1-methylindol-5-yl)imidazo[1,2-a]pyrazin-3-yl]benzamide
ID: ALA3730806
PubChem CID: 117769473
Max Phase: Preclinical
Molecular Formula: C24H21N5O
Molecular Weight: 395.47
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CN(C)C(=O)c1ccc(-c2cnc3cnc(-c4ccc5c(ccn5C)c4)cn23)cc1
Standard InChI: InChI=1S/C24H21N5O/c1-27(2)24(30)17-6-4-16(5-7-17)22-13-26-23-14-25-20(15-29(22)23)18-8-9-21-19(12-18)10-11-28(21)3/h4-15H,1-3H3
Standard InChI Key: UBZTUEWMDPIMEV-UHFFFAOYSA-N
Molfile:
RDKit 2D
30 34 0 0 0 0 0 0 0 0999 V2000
-2.3155 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 -0.7475 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 -1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 0.7475 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 -1.2033 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5889 0.0182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 1.2033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6168 1.4950 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6116 2.9913 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.9220 3.7610 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.9311 0.7345 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1749 2.6315 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2517 3.8078 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8114 5.1995 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2965 5.4106 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2218 4.2301 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6621 2.8384 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8593 6.8019 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3455 7.0110 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.1207 7.7476 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.7956 8.1234 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0842 6.0653 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.2233 1.5042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.2188 2.9992 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.6395 3.4593 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-8.5183 2.2404 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.6467 1.0527 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-8.0129 4.5997 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 6 1 0
5 4 1 0
4 1 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 5 1 0
1 10 1 0
10 11 2 0
11 12 1 0
12 26 2 0
25 13 2 0
13 10 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
9 14 1 0
17 20 1 0
20 21 1 0
20 22 2 0
21 23 1 0
21 24 1 0
25 26 1 0
26 27 1 0
27 28 1 0
28 29 2 0
29 25 1 0
27 30 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 395.47 | Molecular Weight (Monoisotopic): 395.1746 | AlogP: 4.26 | #Rotatable Bonds: 3 |
Polar Surface Area: 55.43 | Molecular Species: NEUTRAL | HBA: 5 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 3.12 | CX LogP: 2.76 | CX LogD: 2.76 |
Aromatic Rings: 5 | Heavy Atoms: 30 | QED Weighted: 0.46 | Np Likeness Score: -1.33 |
References
1. (2014) Nitrogen bicyclic compounds as inhibitors for Scyl1 and Grk5, |